Advertisement

---

ONCOGENEX PHARMACEUTICALS, INC.

OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference

[2013-05-28] -


OncoGenex Announces Plans for the Initiation of the Cedar™ Clinical Trial Evaluating OGX-427 in Combination with Chemotherapy in Advanced Squamous Cell Lung Cancer

[2013-05-23] - OGX-427 ORCA™ Program Expands to Include Second Phase 2 Trial in Patients with Advanced Lung Cancer


OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting

[2013-05-22] - Expanding OGX-427 Clinical Development Program Demonstrates the Company's Commitment to Addressing the Challenge of Cancer Treatment Resistance
"Trials in Progress" Posters will be Presented for Investigational Compounds Custirsen and OGX-427 across Multiple Tumor Types


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers